Analysis of Pseudomonas aeruginosa transcription in an ex vivo cystic fibrosis sputum model identifies metal restriction as a gene expression stimulus

Chronic Pseudomonas aeruginosa lung infections are a distinctive feature of cystic fibrosis (CF) pathology, that challenge adults with CF even with the advent of highly effective modulator therapies. Characterizing P. aeruginosa transcription in the CF lung and identifying factors that drive gene expression could yield novel strategies to eradicate infection or otherwise improve outcomes. To complement published P. aeruginosa gene expression studies in laboratory culture models designed to model the CF lung environment, we employed an ex vivo sputum model in which laboratory strain PAO1 was incubated in sputum from different CF donors. As part of the analysis, we compared PAO1 gene expression in this “spike-in” sputum model to that for P. aeruginosa grown in artificial sputum medium (ASM). Analyses focused on genes that were differentially expressed between sputum and ASM and genes that were most highly expressed in sputum. We present a new approach that used sets of genes with correlated expression, identified by the gene expression analysis tool eADAGE, to analyze the differential activity of pathways in P. aeruginosa grown in CF sputum from different individuals. A key characteristic of P. aeruginosa grown in expectorated CF sputum was related to zinc and iron acquisition, but this signal varied by donor sputum. In addition, a significant correlation between P. aeruginosa expression of the H1-type VI secretion system and corrector use by the sputum donor was observed. These methods may be broadly useful in looking for variable signals across clinical samples. Importance Identifying the gene expression programs used by Pseudomonas aeruginosa to colonize the lungs of people with cystic fibrosis (CF) will illuminate new therapeutic strategies. To capture these transcriptional programs, we cultured the common P. aeruginosa laboratory strain PAO1 in expectorated sputum from CF patient donors. Through bioinformatics analysis, we defined sets of genes that are more transcriptionally active in real CF sputum compared to artificial sputum media (ASM). Many of the most differentially active gene sets contained genes related to metal acquisition, suggesting that these gene sets play an active role in scavenging for metals in the CF lung environment which is inadequately represented in ASM. Future studies of P. aeruginosa transcription in CF may benefit from the use of an expectorated sputum model or modified forms of ASM supplemented with metals.

[1]  Application of a quantitative framework to improve the accuracy of a bacterial infection model , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Hoffman,et al.  Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist , 2023, The Journal of clinical investigation.

[3]  S. Nouraie,et al.  Iron bioavailability regulates Pseudomonas aeruginosa interspecies interactions through type VI secretion expression , 2023, Cell reports.

[4]  Alexandra J. Lee,et al.  Compendium-Wide Analysis of Pseudomonas aeruginosa Core and Accessory Genes Reveals Transcriptional Patterns across Strains PAO1 and PA14 , 2022, mSystems.

[5]  Alexandra J. Lee,et al.  Computationally Efficient Assembly of Pseudomonas aeruginosa Gene Expression Compendia , 2022, mSystems.

[6]  K. Perron,et al.  Zinc homeostasis in Pseudomonas , 2022, BioMetals.

[7]  B. Stanton,et al.  ESKAPE Act Plus: Pathway Activation Analysis for Bacterial Pathogens , 2022, mSystems.

[8]  V. Waters,et al.  Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection. , 2022, Journal of the Pediatric Infectious Diseases Society.

[9]  Z. Gu Complex heatmap visualization , 2022, iMeta.

[10]  M. Greenwald,et al.  The changing landscape of the cystic fibrosis lung environment: From the perspective of Pseudomonas aeruginosa. , 2022, Current opinion in pharmacology.

[11]  D. Hogan,et al.  Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system , 2022, bioRxiv.

[12]  J. Manos,et al.  The Use of Artificial Sputum Media to Enhance Investigation and Subsequent Treatment of Cystic Fibrosis Bacterial Infections , 2022, Microorganisms.

[13]  Anupama Khare,et al.  Systematic identification of molecular mediators of interspecies sensing in a community of two frequently coinfecting bacterial pathogens , 2022, PLoS biology.

[14]  Alexandra J. Lee,et al.  CF-Seq, an accessible web application for rapid re-analysis of cystic fibrosis pathogen RNA sequencing studies , 2022, Scientific Data.

[15]  C. Goss,et al.  Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections , 2021, mBio.

[16]  M. Potvin,et al.  Genome evolution drives transcriptomic and phenotypic adaptation in Pseudomonas aeruginosa during 20 years of infection , 2021, Microbial genomics.

[17]  V. Abbate,et al.  Effect of iron chelation on anti-pseudomonal activity of doxycycline , 2021, International journal of antimicrobial agents.

[18]  V. Phelan,et al.  Impact of Artificial Sputum Medium Formulation on Pseudomonas aeruginosa Secondary Metabolite Production , 2021, Journal of bacteriology.

[19]  L. Hoffman,et al.  Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis. , 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[20]  Zhongyou Li,et al.  GAUGE-Annotated Microbial Transcriptomic Data Facilitate Parallel Mining and High-Throughput Reanalysis To Form Data-Driven Hypotheses , 2021, mSystems.

[21]  F. Vandenesch,et al.  How Bacterial Adaptation to Cystic Fibrosis Environment Shapes Interactions Between Pseudomonas aeruginosa and Staphylococcus aureus , 2021, Frontiers in Microbiology.

[22]  D. Hogan,et al.  Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum , 2021, bioRxiv.

[23]  Eun-Jeong Yoon,et al.  Mobile Carbapenemase Genes in Pseudomonas aeruginosa , 2021, Frontiers in Microbiology.

[24]  J. Boccard,et al.  Metabotypes of Pseudomonas aeruginosa Correlate with Antibiotic Resistance, Virulence and Clinical Outcome in Cystic Fibrosis Chronic Infections , 2021, Metabolites.

[25]  J. Emond‐Rheault,et al.  A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas , 2020, Nature Communications.

[26]  Catherine A. Wakeman,et al.  Pseudomonas aeruginosa polymicrobial interactions during lung infection. , 2020, Current opinion in microbiology.

[27]  R. Rappuoli,et al.  Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia. , 2020, Trends in microbiology.

[28]  L. Chiarelli,et al.  Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients , 2019, International journal of molecular sciences.

[29]  S. Charman,et al.  Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens: A Cohort Study Using National Registry Data. , 2019, Annals of the American Thoracic Society.

[30]  Alexandra J. Lee,et al.  Pseudomonas aeruginosa lasR mutant fitness in microoxia is supported by an Anr-regulated oxygen-binding hemerythrin , 2019, Proceedings of the National Academy of Sciences.

[31]  Bradley S. Turner,et al.  Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection , 2019, Nature Microbiology.

[32]  A. Haverich,et al.  Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung , 2019, Nature Communications.

[33]  L. Peixe,et al.  Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[34]  M. Wolfgang,et al.  Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis , 2019, Science Translational Medicine.

[35]  K. Pardesi,et al.  Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review , 2019, Front. Microbiol..

[36]  S. Johnston Genetic adaptation , 2018, The International Encyclopedia of Biological Anthropology.

[37]  V. Waters,et al.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis , 2018, Clinical Microbiology Reviews.

[38]  M. Mastropasqua,et al.  Efficient zinc uptake is critical for the ability of Pseudomonas aeruginosa to express virulence traits and colonize the human lung. , 2018, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[39]  Katja Koeppen,et al.  ScanGEO: parallel mining of high-throughput gene expression data , 2017, Bioinform..

[40]  C. McDevitt,et al.  The Metallophore Staphylopine Enables Staphylococcus aureus To Compete with the Host for Zinc and Overcome Nutritional Immunity , 2017, mBio.

[41]  Jie Tan,et al.  Unsupervised Extraction of Stable Expression Signatures from Public Compendia with an Ensemble of Neural Networks. , 2017, Cell systems.

[42]  Jie Tan,et al.  ADAGE signature analysis: differential expression analysis with data-defined gene sets , 2017, BMC Bioinformatics.

[43]  R. Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[44]  S. Bleves,et al.  The T6SSs of Pseudomonas aeruginosa Strain PAO1 and Their Effectors: Beyond Bacterial-Cell Targeting , 2016, Front. Cell. Infect. Microbiol..

[45]  M. Whiteley,et al.  Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis , 2015, Microbiology spectrum.

[46]  Elizabeth M. Nolan,et al.  Human Calprotectin Is an Iron-Sequestering Host-Defense Protein , 2015, Nature chemical biology.

[47]  Daniel S. Himmelstein,et al.  Understanding multicellular function and disease with human tissue-specific networks , 2015, Nature Genetics.

[48]  Roland Eils,et al.  circlize implements and enhances circular visualization in R , 2014, Bioinform..

[49]  S. Bell,et al.  Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[50]  M. Schurr,et al.  Iron-Regulated Expression of Alginate Production, Mucoid Phenotype, and Biofilm Formation by Pseudomonas aeruginosa , 2014, mBio.

[51]  A. Filloux Faculty Opinions recommendation of A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. , 2013 .

[52]  I. Schalk,et al.  Pyoverdine biosynthesis and secretion in Pseudomonas aeruginosa: implications for metal homeostasis. , 2013, Environmental microbiology.

[53]  J. Koo,et al.  PilMNOPQ from the Pseudomonas aeruginosa Type IV Pilus System Form a Transenvelope Protein Interaction Network That Interacts with PilA , 2013, Journal of bacteriology.

[54]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[55]  C. W. Davis,et al.  CFTR, mucins, and mucus obstruction in cystic fibrosis. , 2012, Cold Spring Harbor perspectives in medicine.

[56]  R. Gambari,et al.  Oxidative stress and antioxidant therapy in cystic fibrosis. , 2012, Biochimica et biophysica acta.

[57]  B. Stanton,et al.  Iron and CF‐related anemia: Expanding clinical and biochemical relationships , 2011, Pediatric pulmonology.

[58]  J. Lipuma The Changing Microbial Epidemiology in Cystic Fibrosis , 2010, Clinical Microbiology Reviews.

[59]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[60]  G. O’Toole,et al.  Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. , 2009, American journal of respiratory cell and molecular biology.

[61]  Sébastien Lê,et al.  FactoMineR: An R Package for Multivariate Analysis , 2008 .

[62]  B. Rubin Mucus structure and properties in cystic fibrosis. , 2007, Paediatric respiratory reviews.

[63]  Stephen Lory,et al.  A Virulence Locus of Pseudomonas aeruginosa Encodes a Protein Secretion Apparatus , 2006, Science.

[64]  N. Høiby,et al.  Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation , 2005, Antimicrobial Agents and Chemotherapy.

[65]  V. Deretic,et al.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection , 1997, Infection and immunity.

[66]  D. Hassett,et al.  Fumarase C activity is elevated in response to iron deprivation and in mucoid, alginate-producing Pseudomonas aeruginosa: cloning and characterization of fumC and purification of native fumC , 1997, Journal of bacteriology.

[67]  F. Neidhardt,et al.  Culture Medium for Enterobacteria , 1974, Journal of bacteriology.

[68]  B. Stanton,et al.  Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells. , 2015, The Journal of antimicrobial chemotherapy.

[69]  J. Walker,et al.  Bacterial Pathogenesis , 2008, Methods in Molecular Biology™.

[70]  J. Riordan Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA , 1989 .